WealthPLAN Partners’s Protalix BioTherapeutics PLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-575
Closed -$1.15K 913
2023
Q2
$1.15K Buy
+575
New +$1.15K ﹤0.01% 1131